Identification by Mass Spectrometry of a Hemoglobin Variant with an Elongated β-Globin Chain

Philippe Lacan, Michel Becchi, Isabelle Zanella‐Cléon, Martine Aubry, D. Quinsat, Nicole Couprie, Alain Francina

Clinical Chemistry · 2004 · 14 citations · 8 references

DOIFull text

Open access

Concepts

Abstract

Among more than 800 hemoglobin (Hb) variants currently described in the HBVar database of the Globin Gene Server (1), variants with elongated chains are very rare. Standard protein techniques such as ion-exchange HPLC and isoelectric focusing (IEF) on polyacrylamide gel can detect many Hb variants (2), but correct identification of single mutated, inserted, or deleted amino acid residues requires more sophisticated techniques, such as electrospray ionization mass spectrometry (ESI-MS) or matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) (3)(4)(5). The interpretation of DNA sequencing in the presence of inserted nucleotide sequences in the heterozygous state can be difficult and requires direct and reverse sequencing. Protein analysis by MS can be used to check results from DNA sequencing and also can detect posttranslational changes such as acetylation (NH2 terminus), deamidation, methionine oxidation, Hb addition products, or artifacts. ESI-MS and MALDI-TOF MS combined with specific tryptic digestion for peptide mass mapping are rapid and sensitive techniques to confirm inserted amino acid residues. We applied these techniques to the identification of a novel Hb variant with a five-amino acid insertion in the β-globin chain. These techniques allowed us to confirm the DNA sequencing results. Standard Hb analysis was performed by ion-exchange HPLC, IEF on polyacrylamide gel, and reversed-phase (RP)-HPLC of globin chains (6)(7). RP-HPLC was performed with a Vydac C4 analytical column (The Separations Group) with CH3CN–H2O containing 1 mL/L trifluoroacetic acid (TFA) as the mobile phase (7). The same RP-HPLC system was also used for isolation of globin chains for MS studies. Electrospray experiments were performed on a SCIEX API 165 instrument (Applied Biosystems). Solutions were introduced by direct infusion at a flow rate of 5 μL/min. Mass spectra were acquired at a 50-V orifice value in the positive ion mode, and the scan range was set at m/z 650-2150 Th (Thompson). For ESI-MS samples, we prepared a stock solution by diluting the whole blood 50-fold with water and desalting the stock solution by mixing with ∼5 mg of AG 50W-X8 cation-exchange resin (Bio-Rad). We diluted 20 μL of the desalted stock solution by adding 40 μL of CH3OH–H2O (50:50 by volume) containing 1 mL/L HCOOH, and this solution was used for ESI-MS analysis. MALDI-TOF mass spectra were recorded on a Voyager DE-PRO mass spectrometer (Applied Biosystems) in the 700-5000 Da mass range. Use of a delayed extraction source and reflector instrumentation gave sufficient resolution to detect the monoisotopic peptide masses of [M + H]+ ions. For MALDI-TOF sample preparation, we dried 0.5 mL of the 2-mL β-globin chain sample collected from RP-HPLC purification in a vacuum concentrator and redissolved the residue in 90 μL of 50 mmol/L NH4HCO3 buffer. This solution was digested with 10 μL of trypsin solution (Promega; 0.1 g/L in 50 mmol/L NH4HCO3 buffer) for 5 h at 37 °C. We then dried 10 μL of the digest solution in a vacuum concentrator and redissolved it in 10 μL of 1 mL/L TFA. The matrix was a 1 mg (200 μL) solution of α-cyano-4-hydroxycinnamic acid (LaserBioLabs) in CH3CN–H2O (50:50 by volume) containing 1 mL/L TFA. We used the dried-droplet method for sample deposition : 1 μL of the 1 mL/L TFA sample solution and 1 μL of matrix solution were mixed on the target and allowed to dry. DNA studies were carried out by PCR using the following primers: 5′-CAGCTACAATCCAGCTACCATTCTGCT-3′ (forward) and 5′-TAGGCAGAATCCAGATGCTCAAGGCCC-3′ (reverse) (7). Direct sequencing of the PCR products was performed on a Li-Cor 4200 sequencer (ScienceTec) using the same primers labeled with an infrared dye with emission at 700 nm (forward strand) or an infrared dye with emission at 800 nm (reverse strand; MWG-Biotech). Functional studies were made on a Hemox-Analyzer (TCS Scientific Corporation) after stripping of blood hemolysate. Routine protein analysis showed an abnormal Hb band in the IEF gel that migrated between Hb S and Hb A2; this band accounted for 22.6% of the total Hb in ion-exchange HPLC. RP-HPLC analysis of the globin chains detected an abnormal peak 20.62 min after the βA-globin chains (Fig. 1A1 ). ESI-MS analysis revealed a mass of 16307.0 Da (βX) vs 15868.0 for the βA-globin chain (mass shift, +439.0). DNA sequencing revealed an insertion of a short nucleotide sequence, GTGTGCTGGCCC, in exon 3 of the β-globin gene. The same sequence was also found in exon 3 of the wild-type β-globin gene between the second nucleotide of codon 112 and the first nucleotide of codon 116 (Table 11 ). We hypothesized that β116(G18)His was deleted and the peptide sequence Arg-Val-Leu-Ala-His was inserted between β115(G17) and β117(G19) of the normal β-globin chain (Table 11 ). MALDI-TOF MS was performed on a tryptic digest of the βX-globin chain to confirm this interpretation. The βX-chain should contain 150 amino acid residues vs 146 for the normal βA chain with a theoretical mass shift of +439.29. Theoretical masses of tryptic peptides from βX- and βA-chains (8) were compared with the experimentally obtained peptide masses (Table 11 ). The experimentally obtained masses of different peptides were very close to their theoretical masses. The two tryptic peptides, βT12 and βT13, generated by the five-amino acid insertion were characterized by MALDI-TOF MS (Fig. 1B1 ). The present Hb variant was called Hb Antibes-Juan-Les-Pins and was associated with hematologic abnormalities: erythrocytes, 5.41 × 103/L; Hb, 137 g/L; mean corpuscular volume, 78 fL; and mean corpuscular Hb, 25.3 pg. The variant was also found in two children of the same carrier. They presented with the same hematologic abnormalities without iron deficiency. Oxygen dissociation curves performed after stripping with or without the addition of 2,3-diphosphoglycerate or chloride ions were normal. Among MS techniques for studying Hb variants, ESI-MS is the most frequently used and can be associated with peptide sequencing using tandem MS, but it often gives multiply charged fragment ions (4)(5). On the other hand, MALDI-TOF MS gives single-charge peptide ions and has been used for identification of some single-mutation Hb variants (9)(10). The present report shows that MALDI-TOF MS can be use to identify Hb variants. This MALDI-TOF peptide mass fingerprinting method is currently used in our laboratory for abnormal globin chains analysis. The presence of the 12-nucleotide repeat strongly suggests that the origin of this insertion is probably based on a slipped mispairing by DNA polymerase during replication. Such an explanation has been proposed for different Hb variants (11). Amino acid residues at positions β115–β119 at the end of helix G in the normal β-globin chain are involved either in α1β1 subunit links or externally on the Hb molecule (12). The insertion of five amino acid residues leads to the addition of a complete helix turn that has no effect on oxygen binding but decreases molecule stability. Reversed-phase HPLC chromatogram of globin chains (A), and MALDI-TOF MS results for tryptic digests of the βX-globin chain in the range m/z 899-1274 Th (B) and the βA-globin chain in the range m/z 870-2140 Th (C). (A), βA, δ, and αA, normal chains; βX, abnormal globin chain. mAU, milliabsorbance units. Codons, amino acid residues, and tryptic peptides from βX- and βA-globin chains. Italics, single-underlined, or double-underlined indicate the inserted nucleotide sequence: GTGTGCTGGCCC. Expressed in mass-to-charge (m/z) ratio (monoisotopic mass). Codons, amino acid residues, and tryptic peptides from βX- and βA-globin chains. Italics, single-underlined, or double-underlined indicate the inserted nucleotide sequence: GTGTGCTGGCCC. Expressed in mass-to-charge (m/z) ratio (monoisotopic mass).

References

8